A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
NCT00080210
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
Puricase
Sponsor
Savient Pharmaceuticals